View CNVs/SVs
View by Evidence Type: All (
CNVs Only Present In Patients
de novo CNVs
Overlapping/Recurrent CNVs
CNVs Overlapping With ACRD
CNVs Not Present In Control
Significant Enriched CNVs
Others
All
)
View by Chromosome:All ( 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X Y All )
Notes: ACRD: Autism Chromosome Rearrangement Database
| CNV Name | Chr | Band | Gain/Loss | Number of CNVs | Evidence Type | Reference | |
|---|---|---|---|---|---|---|---|
| Case | Control | ||||||
| AutCNV0005032 | 22 | 22q13.31q13.33 | loss | - | - | CNVs Only Present In Patients; | Eriksson MA, 2015 |
| AutCNV0005033 | 22 | 22q13.33 | loss | - | - | CNVs Only Present In Patients; de novo CNVs; | Eriksson MA, 2015 |
| AutCNV0005034 | 9 | 9p24.2 | gain | - | - | CNVs Only Present In Patients; | Eriksson MA, 2015 |
| AutCNV0005035 | 9 | 9q33.1 | loss | - | - | CNVs Only Present In Patients; | Eriksson MA, 2015 |
| AutCNV0005036 | 16 | 16p11.2 | loss | - | - | CNVs Only Present In Patients; | Berman JI, 2015 |
| AutCNV0005037 | 3 | 3q29 | loss | - | - | CNVs Only Present In Patients; | Cox DM, 2015 |
| AutCNV0005038 | 8 | 8q24.3 | loss | - | - | CNVs Only Present In Patients; | Hu J, 2015 |
| AutCNV0005039 | 14 | 14q23.3 | loss | - | - | CNVs Only Present In Patients; | Hu J, 2015 |
| AutCNV0005040 | 3 | 3q24 | loss | - | - | CNVs Only Present In Patients; | Cardon M, 2016 |
| AutCNV0005041 | X | Xq13.3 | gain | - | - | CNVs Only Present In Patients; | Charzewska A, 2015 |
| AutCNV0005042 | - | - | - | - | - | CNVs Only Present In Patients; | Polyak A, 2015 |
| AutCNV0005043 | 2 | 2q33.3q34 | loss | - | - | CNVs Only Present In Patients; de novo CNVs; | Jang DH, 2015 |
| AutCNV0005044 | 22 | 22q13.3 | loss | - | - | CNVs Only Present In Patients; | Philippe A, 2015 |
| AutCNV0005045 | 7 | 7q35 | loss | - | - | CNVs Only Present In Patients; | Rodenas-Cuadrado P, 2016 |
| AutCNV0005046 | 7 | - | loss | - | - | CNVs Only Present In Patients; | Rodenas-Cuadrado P, 2016 |
| AutCNV0005047 | 12 | 12p13.33 | - | - | - | CNVs Only Present In Patients; | Hashemi B, 2015 |
| AutCNV0005048 | 17 | 17p13.3 | - | - | - | CNVs Only Present In Patients; | Hashemi B, 2015 |
| AutCNV0005049 | 16 | 16p12.3 | loss | - | - | CNVs Only Present In Patients; | Jiménez-Barrón LT, 2015 |
| AutCNV0005050 | 3 | 3q22.1 | loss | - | - | CNVs Only Present In Patients; | Jiménez-Barrón LT, 2015 |
| AutCNV0005051 | 4 | 4p16.3 | loss | - | - | CNVs Only Present In Patients; | Jiménez-Barrón LT, 2015 |
| AutCNV0005052 | 16 | 16p11.2 | loss | - | - | CNVs Only Present In Patients; | Duyzend MH, 2016 |
| AutCNV0005053 | 16 | 16p11.2 | gain | - | - | CNVs Only Present In Patients; | Duyzend MH, 2016 |
| AutCNV0005054 | 16 | 16p11.2 | loss | - | - | CNVs Only Present In Patients; de novo CNVs; | Duyzend MH, 2016 |
| AutCNV0005055 | 11 | - | - | - | - | CNVs Only Present In Patients; | Addis L, 2015 |
| AutCNV0005056 | 11 | - | - | - | - | CNVs Only Present In Patients; | Addis L, 2015 |